Enanta Pharmaceuticals (ENTA) Operating Expenses (2016 - 2025)
Historic Operating Expenses for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q4 2025 value amounting to $29.9 million.
- Enanta Pharmaceuticals' Operating Expenses fell 2625.55% to $29.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $140.0 million, marking a year-over-year decrease of 2085.46%. This contributed to the annual value of $150.7 million for FY2025, which is 2041.61% down from last year.
- Enanta Pharmaceuticals' Operating Expenses amounted to $29.9 million in Q4 2025, which was down 2625.55% from $33.5 million recorded in Q3 2025.
- Enanta Pharmaceuticals' 5-year Operating Expenses high stood at $58.1 million for Q4 2021, and its period low was $29.9 million during Q4 2025.
- For the 5-year period, Enanta Pharmaceuticals' Operating Expenses averaged around $47.9 million, with its median value being $49.9 million (2021).
- Per our database at Business Quant, Enanta Pharmaceuticals' Operating Expenses skyrocketed by 3364.9% in 2021 and then plummeted by 2625.55% in 2025.
- Enanta Pharmaceuticals' Operating Expenses (Quarter) stood at $58.1 million in 2021, then dropped by 7.68% to $53.6 million in 2022, then decreased by 1.32% to $52.9 million in 2023, then decreased by 23.42% to $40.5 million in 2024, then dropped by 26.26% to $29.9 million in 2025.
- Its Operating Expenses stands at $29.9 million for Q4 2025, versus $33.5 million for Q3 2025 and $37.2 million for Q2 2025.